Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_assertion type Assertion NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_head.
- NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_assertion description "[Dacomitinib was well tolerated and had antitumor activity in Korean patients with NSCLC who had previously progressed on chemotherapy and an epidermal growth factor receptor tyrosine kinase inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_provenance.
- NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_assertion evidence source_evidence_literature NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_provenance.
- NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_assertion SIO_000772 25521398 NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_provenance.
- NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_assertion wasDerivedFrom befree-2016 NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_provenance.
- NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_assertion wasGeneratedBy ECO_0000203 NP1249192.RAIsQIEQZIrfAdy3CqoGixyS1GHZfDFi82wY4GVrCIkno130_provenance.